Sven Håkan Björklund is a Swedish businessperson who has been the head of 24 different companies. Presently, he is Chairman of Jordberga Gård AB, Chairman of Gyllebo Slott AB, Chairman for Kibacq AB, Chairman of Trimb Holding AB, Chairman at Swedish Orphan Biovitrum AB and Chairman for Trimb Healthcare AB. Dr. Björklund is also on the board of BONESUPPORT HOLDING AB (former Chairman) and BONE SUPPORT AB (former Chairman) and Partner at Tellacq AB.
He previously occupied the position of Chairman-Supervisory Board at QIAGEN NV and Chairman-Supervisory Board of QIAGEN GmbH (a subsidiary of QIAGEN NV), Chairman at Fougera Luxco SA, Chief Executive Officer of Nycomed AB, Chief Executive Officer of Nycomed Luxco SA, President for Astra Pain Control AB, Head of Biological Research at Pharmacia Ophthalmics AB, Regional Director at AstraZeneca Plc President at Astra Draco AB and Regional Director at Astra AB (both are subsidiaries of AstraZeneca Plc), Chairman of Fougera Pharmaceuticals, Inc., Chairman of Acino International AG, Chairman for H. Lundbeck A, Chairman of Acino Pharma AG, Chief Executive Officer of Takeda A, Chief Executive Officer for Takeda Pharmaceuticals International GmbH, Chief Executive Officer for Nyco Holdings 2 ApS, Chief Executive Officer at Nycomed Pharma Holding An and President at Astra Paint (Pvt) Ltd.
Sven Håkan Björklund received a doctorate from Karolinska Institutet.